… the latest body of evidence and ongoing research on the development of pharmacological
therapies for COVID-19. … , prophylactic treatments, and therapeutic modalities for COVID-19. …

… of coronavirus disease 2019 (COVID-19), which is imposing the worst infectious disease
crisis … The extent to which COVID-19 is complicated by bacterial or fungal superinfections is …

… The Coronavirus disease 2019 (COVID-19) pandemic has … potential approaches to
pharmacologically fight COVID-19: small-… a critical target for vaccine development. …

… (severe acute respiratory syndrome coronavirus 2) is a global … To combat the spread of
COVID-19, more than 100 applicant … of the current developments of potential COVID-19 vaccines …

… All contacts including healthcare workers should be monitored for development of symptoms
of COVID-19. Patients can be discharged from isolation once they are afebrile for atleast 3 …

… To this day, the coronavirus disease 2019 (COVID-19) pandemic … latest advances in
development, reliable platforms, strategies used, and challenges that remain in developing COVID…

… December 2019 saw the outbreak of a novel beta-coronavirus from Wuhan, China. …
coronavirus 2 (SARS-CoV-2), and the corresponding disease – coronavirus disease 2019 (COVID-19…

… development of new treatment and a successful vaccine to protect public health worldwide
and prevent future COVID-… for the development of targeted drugs and vaccines for COVID-19 …

… of coronavirus N proteins and how these features provide insights into structure-based
development of therapeutics against coronaviruses. We will also present our latest results on …

… coronavirus disease 2019 (COVID-19), is caused by a novel CoV, namely severe acute
respiratory syndrome coronavirus … However, the development of drugs for pathogenic SARS-CoV…